Shares of Moderna (NASDAQ: MRNA) were jumping 7.4% higher as of 3:42 p.m. EDT on Wednesday. The gain came after the company announced that it won a new deal to supply its COVID-19 vaccine to Israel for 2022.
Moderna didn't reveal how many doses are included in its latest agreement with Israel. However, Israeli news organization Ynet reported earlier this week that Israel was buying 7.2 million doses of the company's COVID-19 vaccine for around 0.5 billion shekels, which equates to roughly $150 million.
Image source: Getty Images.
Source Fool.com